Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Charles G. Drake, MD, PhD, director of Genitourinary Oncology, NewYork-Presbyterian/Columbia University Medical Center and co-director of Columbia’s Cancer Immunotherapy Programs, discusses the results of the CARMENA study in patients with metastatic renal cell carcinoma.
 

Dr. Drake Discusses the Results of the CARMENA Study in RCC

Providing comprehensive, compassionate, cost-effective care has been the guiding principle of Urology San Antonio. The practice manages over 200,000 visits and establishes relationships with more than 22,000 new patients each year.

Practice in South Texas Offers Vertically Integrated Cancer Care

Future Directions for Research in mRCC

PD-L1 Testing in mRCC

Novel Combination Therapies Under Investigation in mRCC

Emerging TKI/I-O Options in mRCC

TKI/I-O Therapy in mRCC

Therapeutic Sequencing in mRCC

Managing Patients on Lenvatinib/Everolimus in mRCC

Lenvatinib and Everolimus in Relapsed/Refractory mRCC

Second-Line Combination Therapy in mRCC

Making Decisions for Second-Line Therapy in mRCC

Antiangiogenic Resistance in mRCC

Bevacizumab and Interferon in mRCC

Nivolumab and Ipilimumab in mRCC

Cabozantinib in mRCC

Rationale for Combination Therapy in mRCC

Historical Perspectives on the Treatment of mRCC

Toni K. Choueiri, MD, discusses some of the most significant data presented thus far in 2018 for the treatment of patients with renal cell carcinoma. 

Choueiri Reflects on Recent RCC Advances

Peter J. Van Veldhuizen, MD, discusses available and emerging therapies for patients with kidney cancer.

Novel Combinations Advance Through RCC Pipeline

Urothelial Cancer

The OncLive Urology condition center page is a comprehensive resource for clinical news and expert insights on urologic cancers, including prostate cancer, bladder cancer, testicular cancer, penile cancer, and renal cell carcinoma. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in brain cancer.

Prostate Cancer

The OncLive Prostate Cancer condition center page is a comprehensive resource for clinical news and expert insights on how to approach treatment for patients with nonmetastatic, castration-resistant, or castration-sensitive prostate cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, ongoing research, and treatment advances with androgen receptor inhibitors, PARP inhibitors, and more in prostate cancer.

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, including renal cell carcinoma, urothelial carcinoma, and prostate cancer. This section features news articles, interviews in written and video format, and podcasts that focus on the evolving treatment paradigm of GU cancers and emerging research. 

Genitourinary Cancers | Specialty